| Dr Jonathan T Locke, MD | |
|
2300 N Edward St, Decatur, IL 62526-4163 | |
| (217) 876-2300 | |
| (217) 876-6725 |
| Full Name | Dr Jonathan T Locke |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 35 Years |
| Location | 2300 N Edward St, Decatur, Illinois |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1982650990 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Decatur Memorial Hospital | Decatur, IL | Hospital |
| St Marys Hospital | Decatur, IL | Hospital |
| Pana Community Hospital | Pana, IL | Hospital |
| St Anthonys Memorial Hospital | Effingham, IL | Hospital |
| St Johns Hospital | Springfield, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Imaging Consultants Of Central Illinois Sc | 6800275900 | 9 |
News Archive
While more patients in the U.S. are suffering from complications such as blood clots and infections after major cancer surgery, fewer are dying from their operations.
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
"New ideas and approaches to the water and food nexus will be addressed at World Water Week," which will take place in Stockholm, Sweden from 26-31 August, Anders Jagerskog, an associate professor and director of knowledge services at the Stockholm International Water Institute (SIWI), writes in this post in the AlertNet Blog.
A decline in contributions from the WHO's leading 30 "traditional" donor nations and the exchange rate for the weaker U.S. dollar are causing the agency to cut its budget and staff, WHO Director-General Margaret Chan told reporters in a news conference at the World Health Assembly in Geneva on Tuesday, the Associated Press reports.
› Verified 5 days ago
| Entity Name | Springfield Clinic Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780638478 PECOS PAC ID: 0547166076 Enrollment ID: O20040331000826 |
News Archive
While more patients in the U.S. are suffering from complications such as blood clots and infections after major cancer surgery, fewer are dying from their operations.
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
"New ideas and approaches to the water and food nexus will be addressed at World Water Week," which will take place in Stockholm, Sweden from 26-31 August, Anders Jagerskog, an associate professor and director of knowledge services at the Stockholm International Water Institute (SIWI), writes in this post in the AlertNet Blog.
A decline in contributions from the WHO's leading 30 "traditional" donor nations and the exchange rate for the weaker U.S. dollar are causing the agency to cut its budget and staff, WHO Director-General Margaret Chan told reporters in a news conference at the World Health Assembly in Geneva on Tuesday, the Associated Press reports.
› Verified 5 days ago
| Entity Name | Decatur Radiology Physicians Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881640977 PECOS PAC ID: 1658353974 Enrollment ID: O20040602000158 |
News Archive
While more patients in the U.S. are suffering from complications such as blood clots and infections after major cancer surgery, fewer are dying from their operations.
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
"New ideas and approaches to the water and food nexus will be addressed at World Water Week," which will take place in Stockholm, Sweden from 26-31 August, Anders Jagerskog, an associate professor and director of knowledge services at the Stockholm International Water Institute (SIWI), writes in this post in the AlertNet Blog.
A decline in contributions from the WHO's leading 30 "traditional" donor nations and the exchange rate for the weaker U.S. dollar are causing the agency to cut its budget and staff, WHO Director-General Margaret Chan told reporters in a news conference at the World Health Assembly in Geneva on Tuesday, the Associated Press reports.
› Verified 5 days ago
| Entity Name | Imaging Consultants Of Central Illinois Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427796838 PECOS PAC ID: 6800275900 Enrollment ID: O20220621001058 |
News Archive
While more patients in the U.S. are suffering from complications such as blood clots and infections after major cancer surgery, fewer are dying from their operations.
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
"New ideas and approaches to the water and food nexus will be addressed at World Water Week," which will take place in Stockholm, Sweden from 26-31 August, Anders Jagerskog, an associate professor and director of knowledge services at the Stockholm International Water Institute (SIWI), writes in this post in the AlertNet Blog.
A decline in contributions from the WHO's leading 30 "traditional" donor nations and the exchange rate for the weaker U.S. dollar are causing the agency to cut its budget and staff, WHO Director-General Margaret Chan told reporters in a news conference at the World Health Assembly in Geneva on Tuesday, the Associated Press reports.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan T Locke, MD 2300 N Edward St, Decatur, IL 62526-4163 Ph: (217) 876-2300 | Dr Jonathan T Locke, MD 2300 N Edward St, Decatur, IL 62526-4163 Ph: (217) 876-2300 |
News Archive
While more patients in the U.S. are suffering from complications such as blood clots and infections after major cancer surgery, fewer are dying from their operations.
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
"New ideas and approaches to the water and food nexus will be addressed at World Water Week," which will take place in Stockholm, Sweden from 26-31 August, Anders Jagerskog, an associate professor and director of knowledge services at the Stockholm International Water Institute (SIWI), writes in this post in the AlertNet Blog.
A decline in contributions from the WHO's leading 30 "traditional" donor nations and the exchange rate for the weaker U.S. dollar are causing the agency to cut its budget and staff, WHO Director-General Margaret Chan told reporters in a news conference at the World Health Assembly in Geneva on Tuesday, the Associated Press reports.
› Verified 5 days ago
Dr. Jeffrey Marc Boorstein, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 2300 N Edward St, Decatur, IL 62526 Phone: 217-876-2300 Fax: 217-876-6725 | |
Soman Nair, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1800 E Lake Shore Dr, Decatur, IL 62521 Phone: 217-464-2984 Fax: 217-464-1631 | |
Harold A Yoon, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 W Mckinley Ave Ste 1, Decatur, IL 62526 Phone: 217-877-9442 Fax: 217-233-1670 | |
Mrs. Mary Anne Depaz, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 W. Mckinley Ave, Ste 2, Decatur, IL 62526 Phone: 217-876-6600 Fax: 217-876-6606 | |
Mr. Edward C Elliott Ii, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 210 W. Mckinley Ave, Ste 1, Decatur, IL 62526 Phone: 217-876-6600 Fax: 217-876-6606 | |
Dr. Renata Charissa Moore, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1990 E Lake Shore Dr, Decatur, IL 62521 Phone: 217-464-2900 Fax: 217-464-2909 | |
Dr. Mark A Muscato, MD Radiology Medicare: May Accept Medicare Assignments Practice Location: 2300 N Edward St, Decatur, IL 62526 Phone: 217-876-2300 Fax: 217-876-6725 |